V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004753 | 290003478 | 1.72 | 79.8 | Neo-adjuvant (N) | 2016-03-16 | 2016-03-31 | Capecitabine + Cisplatin + RT | 02 | N | 290021730 | CETUXIMAB + OXALIPLATIN + MDG |
| 290004754 | 290003479 | 1.77 | null | Palliative (P) | 2015-11-27 | 2015-11-27 | Capecitabine | N | N | 290021734 | CETUXIMAB + RT |
| 290004755 | 290003480 | 1.63 | 107.6 | Adjuvant (A) | 2015-05-14 | 2015-06-17 | FCarboSt | 2 | N | 290021735 | CAPECITABINE |
| 290004756 | 290003480 | 1.82 | 0 | Palliative (P) | 2017-01-07 | 2017-01-12 | CAPECITABINE + CARBOPLATIN | N | N | 290021735 | LANREOTIDE |
| 290004757 | 290003481 | 1.46 | 72.7 | Palliative (P) | 2016-02-27 | 2016-03-07 | Carboplatin + Paclitaxel (weekly) | 2 | null | 290021740 | CARBO + FLUOROURACIL |
| 290004758 | 290003481 | 1.75 | 85 | null | null | 2015-09-22 | Carboplatin + Etoposide iv&po | null | null | 290021740 | EOX |
| 290004759 | 290003482 | null | 39.7 | Palliative (P) | null | 2013-11-24 | CARBOPLATIN + RT | N | N | 290021743 | FLUOROURACIL |
| 290004760 | 290003483 | 1.64 | 75.7 | Disease modification (D) | 2014-04-24 | 2014-04-25 | Bevacizumab 5mg/kg | 2 | N | 290021744 | CAPECITABINE |
| 290004761 | 290003484 | 1.57 | null | Palliative (P) | 2014-05-26 | 2014-05-26 | Capecitabine | N | N | 290021745 | LANREOTIDE |
| 290004762 | 290003485 | null | null | Curative (C) | 2014-12-04 | 2014-12-04 | CISPLATIN + VINORELBINE | 02 | N | 290021746 | CARBOPLATIN + ETOPOSIDE |
| 290004763 | 290003486 | 0 | 93.9 | Neo-adjuvant (N) | 2015-07-20 | 2015-08-03 | MITOMYCIN | 02 | Y | 290021747 | CISPLATIN + GEMCITABINE |
| 290004764 | 290003487 | 1.4 | 53 | Neo-adjuvant (N) | 2018-05-24 | 2018-05-25 | Capecitabine 35days + RT | 02 | N | 290021748 | CISPLATIN + FLUOROURACIL |
| 290004765 | 290003488 | null | null | Palliative (P) | 2013-08-15 | 2013-08-21 | CARBOPLATIN + RT | N | N | 290021749 | FLUOROURACIL |
| 290004766 | 290003489 | 1.62 | 52.4 | Neo-adjuvant (N) | 2015-06-12 | 2015-06-14 | Capecitabine | N | Y | 290021751 | CARBOPLATIN + RT |
| 290004767 | 290003490 | 1.87 | 54.8 | Curative (C) | 2014-10-18 | 2014-11-06 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | Y | 290021752 | CARBOPLATIN |
| 290004768 | 290003491 | 1.76 | 86 | Neo-adjuvant (N) | 2017-09-08 | 2017-09-17 | CARBOPLATIN + RT | 02 | N | 290021754 | CAPECITABINE + RT |
| 290004769 | 290003491 | 1.62 | 60 | Curative (C) | 2014-06-03 | 2014-11-17 | Capecitabine | N | N | 290021754 | CARBOPLATIN |
| 290004770 | 290003492 | 1.69 | 85 | Curative (C) | 2014-02-10 | 2014-02-24 | CISPLATIN + FLUOROURACIL | N | Y | 290021762 | CAPECITABINE + RT |
| 290004771 | 290003493 | 1.6 | 51 | Palliative (P) | 2017-02-12 | 2017-02-17 | Pazopanib | 02 | N | 290021763 | CETUXIMAB + RT |
| 290004772 | 290006547 | 1.84 | 91 | Adjuvant (A) | 2013-06-08 | 2013-06-13 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021764 | CISPLATIN + ETOPOSIDE |
| 290004773 | 290003494 | 1.7 | 67.3 | Neo-adjuvant (N) | null | 2016-11-16 | Carboplatin AUC 2 - 5 | N | Y | 290021767 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004774 | 290003495 | 1.77 | 75.1 | Palliative (P) | 2013-05-14 | 2013-05-14 | Gemcitabine + Capecitabine | 02 | N | 290021768 | CISPLATIN + FLUOROURACIL |
| 290004775 | 290003496 | 1.8 | null | Curative (C) | 2017-09-28 | 2017-10-04 | OCTREOTIDE | N | N | 290021770 | CETUXIMAB |
| 290004776 | 290003497 | 1.72 | 97.2 | Palliative (P) | 2015-10-19 | 2015-11-16 | LANREOTIDE | 2 | N | 290021771 | OCTREOTIDE |
| 290004777 | 290003497 | 1.74 | 66.4 | null | null | 2013-07-14 | Capecitabine | null | null | 290021771 | FLUOROURACIL |
| 290004778 | 290003498 | 0 | 70.8 | Adjuvant (A) | 2017-08-13 | 2017-09-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290021773 | CAPECITABINE + RT |
| 290004779 | 290003499 | 1.68 | 53.4 | Palliative (P) | null | 2017-04-30 | LANREOTIDE | N | N | 290021774 | CAPECITABINE |
| 290004780 | 290003499 | 1.78 | 56.8 | Adjuvant (A) | 2015-11-21 | 2015-12-11 | LANREOTIDE | N | N | 290021774 | CAPECITABINE + RT |
| 290004781 | 290003499 | 0 | 53.8 | Palliative (P) | 2014-04-03 | 2014-04-14 | CISPLATIN + FLUOROURACIL | N | N | 290021774 | FLUOROURACIL |
| 290004782 | 290003500 | null | 59 | null | 2014-03-31 | 2014-04-21 | Capecitabine 35days + RT | null | null | 290021778 | FCARBOST |
| 290004783 | 290003501 | null | 65 | Palliative (P) | 2018-01-06 | 2018-01-20 | OCTREOTIDE | null | N | 290021780 | CISPLATIN + FLUOROURACIL + RT |
| 290004784 | 290006550 | null | null | Radical (R) | 2015-10-09 | 2015-10-13 | ECX | N | N | 290021783 | MCX |
| 290004785 | 290003502 | 1.7 | 101 | Palliative (P) | 2013-09-17 | 2013-10-13 | Cetuximab 7 day (Cycle 1) | N | N | 290021785 | CETUXIMAB + RT |
| 290004786 | 290003503 | 1.69 | 49.4 | Neo-adjuvant (N) | 2018-09-20 | 2018-09-23 | Capecitabine 35days + RT | 02 | N | 290021786 | CAPECITABINE + TEMOZOLOMIDE |
| 290004787 | 290003504 | 1.69 | null | Palliative (P) | null | 2014-05-17 | ECF | N | N | 290021787 | CAPECITABINE + CISPLATIN |
| 290004788 | 290003504 | 1.63 | 56.6 | Curative (C) | 2014-01-07 | 2014-01-10 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 290021787 | DOCETAXEL |
| 290004789 | 290003505 | null | 67 | Neo-adjuvant (N) | 2017-11-18 | 2018-05-06 | Capecitabine 42days + RT | 02 | N | 290021791 | TEMOZOLOMIDE |
| 290004790 | 290003506 | 1.8 | 70.5 | null | 2013-06-25 | 2013-06-25 | EOX | 02 | null | 290021794 | DOCETAXEL |
| 290004791 | 290003506 | 1.55 | 76.1 | Curative (C) | 2014-06-02 | 2014-06-04 | EOX | 02 | Y | 290021794 | CAPECITABINE + RT |
| 290004792 | 290003507 | 1.65 | 77.8 | Disease modification (D) | 2015-10-29 | 2015-11-11 | MCX | N | N | 290021798 | OCTREOTIDE |
| 290004793 | 290006553 | 1.61 | 67.2 | Palliative (P) | 2016-12-31 | 2017-01-06 | CETUXIMAB + CISPLATIN + FU | 02 | null | 290021800 | IRINOTECAN |
| 290004794 | 290006553 | null | null | Palliative (P) | 2016-02-15 | 2016-02-16 | Capecitabine | 02 | N | 290021800 | CARBOPLATIN |
| 290004795 | 290006553 | 1.72 | 64.6 | null | 2014-07-11 | 2014-07-14 | Carboplatin AUC 6 - 10 | 2 | N | 290021800 | CARBOPLATIN + RT |
| 290004796 | 290003508 | 1.64 | 44 | null | 2015-06-22 | 2015-07-07 | ECX | 02 | N | 290021803 | CAPECITABINE |
| 290004797 | 290003508 | null | 62.8 | Adjuvant (A) | 2016-12-21 | 2017-01-11 | METHOTREXATE | N | 2 | 290021803 | CAPECITABINE + RT |
| 290004798 | 290003509 | null | 57.7 | Palliative (P) | 2018-01-31 | 2018-02-08 | Capecitabine | null | N | 290021807 | LANREOTIDE |
| 290004799 | 290003510 | 1.67 | 68 | Curative (C) | 2016-07-24 | 2016-08-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | Y | 290021808 | CAPECITABINE |
| 290004800 | 290003511 | null | 42 | Palliative (P) | 2015-11-24 | 2015-12-25 | Capecitabine 35days + RT | Y | N | 290021812 | DOXORUBICIN + OLARATUMAB |
| 290004801 | 290006555 | null | 73 | Palliative (P) | 2016-03-17 | 2016-03-23 | PACLITAXEL | 02 | N | 290021817 | GEMCITABINE |
| 290004802 | 290003512 | 1.72 | 73 | Not known (9) | 2014-10-14 | 2014-10-14 | Cisplatin+Gemcitabine (gallbladder) | 2 | null | 290021819 | CARBO + FLUOROURACIL |